Every year an appreciable number of drugs are withdrawn from the market, or their uses are curtailed by black box warnings, due to some adverse effect that was not discovered during preclinical and clinical testing. New assays for mitochondrial function (many of which were developed by MitoSciences) have revealed strong mitochondrial impairment by several previously withdrawn drugs, including cerivastatin (Baycol), troglitazone (Rezulin), nefazodone (Serzone), and tolcapone. Not surprisingly, there is now much more focus on identifying mitochondrial toxicity early in the development process.

Cat. No.	Name
ab140100	Cellular acid extrusion probe
MS955	CFSE - Cell Labeling Kit
MS958	DCFDA - Cellular Reactive Oxygen Species Detection Assay Kit
ab140097	Extracellular Oxygen (O2) probe
ab140099	Extracellular Oxygen (O2) probe (with high-sensitivity oil)
ab140098	Extracellular Oxygen (O2) probe (with mineral oil)
ab140101	Intracellular Oxygen (O2) probe
MS959	JC1 - Mitochondrial Membrane Potential Assay Kit
MS961	Live/Dead Cell Assay
ab129732	Mitochondrial Viability Stain
MTOXC	MitoTox™ Complete OXPHOS Activity Assay Panel
MTOX1	MitoTox™ Complex I OXPHOS Activity Assay Kit
MTOX2	MitoTox™ Complex II OXPHOS Activity Assay Kit
MTOX3	MitoTox™ Complex III OXPHOS Activity Assay Kit
MTOX4	MitoTox™ Complex IV OXPHOS Activity Assay Kit
MTOX5	MitoTox™ Complex V OXPHOS Activity Assay Kit
ab178020	Oxidized Protein Western Blot Kit
ab190804	Thioredoxin Reductase 1 (TXNRD1) Activity Assay Kit
MS960	TMRE Mitochondrial Membrane Potential Assay Kit